Sarfati D, Gurney J (2022) Preventing cancer: the only way forward. Lancet (London, England) 400(10352):540–541

Article  PubMed  Google Scholar 

D. Sifaki-Pistolla, et al., Evidence-based conceptual collection of methods for spatial epidemiology and analysis to enhance cancer surveillance and public health. Int J Environ Res Public Health, 2022. 19(19).

Morrone FB et al (2021) P2Y12 purinergic receptor and brain tumors: implications on Glioma Microenvironment. Molecules (Basel, Switzerland) 26(20)

Liverani E et al (2014) The role of P2Y12 receptor and activated platelets during inflammation. Curr Drug Targets 15(7):720–728

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mege D et al (2019) Involvement of platelets in cancers. Semin Thromb Hemost 45(6):569–575

Article  CAS  PubMed  Google Scholar 

Bellefeuille SD, Molle CM, Gendron FP (2019) Reviewing the role of P2Y receptors in specific gastrointestinal cancers. Purinergic Signal 15(4):451–463

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gresele P, Malvestiti M, Momi S (2018) Anti-platelet treatments in cancer: basic and clinical research. Thromb Res 164(Suppl 1):S106–S111

Article  CAS  PubMed  Google Scholar 

Davis PJ et al (2020) Platelet ATP, thyroid hormone receptor on integrin αvβ3 and cancer metastasis. Hormones & Cancer 11(1):13–16

Article  Google Scholar 

Li N (2016) Platelets in cancer metastasis: to help the “villain” to do evil. Int J Cancer 138(9):2078–2087

Article  CAS  PubMed  Google Scholar 

Cecerska-Heryć E et al (2022) Applications of the regenerative capacity of platelets in modern medicine. Cytokine Growth Factor Rev 64:84–94

Article  PubMed  Google Scholar 

Radziwon-Balicka A, Moncada de la Rosa C, Jurasz P (2012) Platelet-associated angiogenesis regulating factors: a pharmacological perspective. Can J Physiol Pharmacol 90(6):679–688

Article  CAS  PubMed  Google Scholar 

Dovizio M et al (2018) Platelets and extracellular vesicles in cancer: diagnostic and therapeutic implications. Cancer Metastasis Rev 37(2-3):455–467

Article  PubMed  Google Scholar 

Mezouar S et al (2015) Inhibition of platelet activation prevents the P-selectin and integrin-dependent accumulation of cancer cell microparticles and reduces tumor growth and metastasis in vivo. Int J Cancer 136(2):462–475

Article  CAS  PubMed  Google Scholar 

Burnstock G (2017) Purinergic signaling in the cardiovascular system. Circ Res 120(1):207–228

Article  CAS  PubMed  Google Scholar 

Hu JL, Zhang WJ (2023) The role and pharmacological properties of P2Y12 receptor in cancer and cancer pain. Biomed Pharmacother 157:113927

Article  CAS  PubMed  Google Scholar 

Kaufmann CC et al (2019) Is P2Y12 inhibitor therapy associated with an increased risk of cancer? Eur Heart J Cardiovasc Pharmacother 5(2):100–104

Article  PubMed  Google Scholar 

Smeda M et al (2018) Dual antiplatelet therapy with clopidogrel and aspirin increases mortality in 4T1 metastatic breast cancer-bearing mice by inducing vascular mimicry in primary tumour. Oncotarget 9(25):17810–17824

Article  PubMed  PubMed Central  Google Scholar 

Takasaki J et al (2001) Molecular cloning of the platelet P2T(AC) ADP receptor: pharmacological comparison with another ADP receptor, the P2Y(1) receptor. Mol Pharmacol 60(3):432–439

CAS  PubMed  Google Scholar 

Fontana P et al (2003) Adenosine diphosphate-induced platelet aggregation is associated with P2Y12 gene sequence variations in healthy subjects. Circulation 108(8):989–995

Article  CAS  PubMed  Google Scholar 

Zhang K et al (2014) Structure of the human P2Y12 receptor in complex with an antithrombotic drug. Nature 509(7498):115–118

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cattaneo M (2011) The platelet P2Y12 receptor for adenosine diphosphate: congenital and drug-induced defects. Blood 117(7):2102–2112

Article  CAS  PubMed  Google Scholar 

Simon J, Barnard EA (2003) The P2Y nucleotide receptors in the human genome. Acta Biol Hung 54(2):191–201

Article  CAS  PubMed  Google Scholar 

Unterberger U et al (2002) Inhibition of adenylyl cyclase by neuronal P2Y receptors. Br J Pharmacol 135(3):673–684

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang FL et al (2001) ADP is the cognate ligand for the orphan G protein-coupled receptor SP1999. J Biol Chem 276(11):8608–8615

Article  CAS  PubMed  Google Scholar 

Simon J et al (2002) Characterization and channel coupling of the P2Y(12) nucleotide receptor of brain capillary endothelial cells. J Biol Chem 277(35):31390–31400

Article  CAS  PubMed  Google Scholar 

Abbracchio MP et al (2006) International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy. Pharmacol Rev 58(3):281–341

Article  CAS  PubMed  Google Scholar 

von Kügelgen I (2006) Pharmacological profiles of cloned mammalian P2Y-receptor subtypes. Pharmacol Ther 110(3):415–432

Article  Google Scholar 

Zhang J et al (2014) Agonist-bound structure of the human P2Y12 receptor. Nature 509(7498):119–122

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hollopeter G et al (2001) Identification of the platelet ADP receptor targeted by antithrombotic drugs. Nature 409(6817):202–207

Article  CAS  PubMed  Google Scholar 

Wihlborg A-K et al (2004) ADP receptor P2Y12 is expressed in vascular smooth muscle cells and stimulates contraction in human blood vessels. Arterioscler Thromb Vasc Biol 24(10):1810–1815

Article  CAS  PubMed  Google Scholar 

Gachet C (2012) P2Y(12) receptors in platelets and other hematopoietic and non-hematopoietic cells. Purinergic Signal 8(3):609–619

Article  CAS  PubMed  PubMed Central  Google Scholar 

Storey RF et al (2000) The central role of the P (2T) receptor in amplification of human platelet activation, aggregation, secretion and procoagulant activity. Br J Haematol 110(4):925–934

Article  CAS  PubMed  Google Scholar 

Cattaneo M (2015) P2Y12 receptors: structure and function. J Thromb Haemost 13(Suppl 1):S10–S16

Article  CAS  PubMed  Google Scholar 

Puri RN, Colman RW (1997) ADP-induced platelet activation. Crit Rev Biochem Mol Biol 32(6):437–502

Article  CAS  PubMed